Venture capital (VC) funding activity by the US startups experienced a year-on-year (YoY) decline both in terms of deals volume and value during January-April 2024. A total of 1,527 VC deals of worth $34.2 billion were announced in the US during January-April 2024. This represents a YoY decline of 47.7% in terms of deals volume and 28.7% in terms of value, according to GlobalData, a leading data and analytics company.

An analysis of GlobalData’s Deals Database revealed that a total of 2,922 VC funding deals were announced in the US during January-April 2023 while the total disclosed funding value of these stood at $47.9 billion.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Market volatility seems to have impacted the investors’ confidence in VC funding deal making activity in the US. However, despite the decline, the US continued to lead the global VC funding landscape in terms of deals volume as well as value.”

The US accounted for 28% share of the total number of VC funding deals announced globally during January-April 2024 while its share of the corresponding disclosed funding value stood at 45.2%.

Bose adds: “Despite the market volatility, the US’ attractiveness continues to remain among VC investors, which is also evident from the fact that it accounted for close to half of total venture capital raised globally during the review period.”

Some of the notable VC funding deals announced in the US during January-April 2024 include $1 billion raised by Xaira Therapeutics, $700 million raised by Wonder, $675 million raised by Figure AI, $520 million raised by Nexamp and $400 million raised by Mirador Therapeutics.

Note: Historic data may change in case some deals get added to previous months because of a delay in disclosure of information in the public domain.